Please assess the completion status of the following clinical trial:

Trial Title: Streamlined Genetic Testing in Prostate Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male~* Diagnosed with metastatic prostate cancer or Gleason 7+ prostate cancer~* Diagnosed between 2010-2020~Exclusion Criteria:~* Age 81 or older~* Previous cancer genetic counseling or testing~* Previously scheduled for cancer genetic counseling or testing~* Cannot participate in English~* Are not capable of providing informed consent

- Gender: MALE
- Minimum Age: 21 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Proactive Streamlined Genetic Education and Testing (Type: EXPERIMENTAL): Participants randomized to this arm will proactively receive genetic education print materials and the option to proceed directly with genetic testing.
- Usual Care (Type: ACTIVE_COMPARATOR): Participants in this arm will be sent a referral letter recommending that they schedule a genetic counseling session and providing them with contact information to do so.

Based on this trial design, predict the completion outcome and termination type (if applicable).